(+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one] | 480446-38-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: (+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one]
• 英文别名: 3-[3-[[(1S,2S,4R)-2-bicyclo[2.2.1]heptanyl]oxy]-4-methoxyanilino]-2-methylcyclopent-2-en-1-one
• CAS: 480446-38-6
• 化学式: C₂₀H₂₅NO₃
• 分子量: 327.423
• InChiKey: RXMKCAKTLINOTO-TYILLQQXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  3-[3-[(1RS,2RS,4SR)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one 生成 (-)-3-[3-[(1R, 2R, 4S)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one 、 (+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one]
  参考文献：
  名称：

  EP1405844

  摘要：

  公开号：

文献信息

• CYCLOALKENONE DERIVATIVE
  申请人：Nikken Chemicals Company, Limited

  公开号：EP1405844A1

  公开（公告）日：2004-04-07

  (-)-3-[3-[(1R, 2R, 4S)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one, or its hydrate or solvate, or a pharmaceutical composition containing the same.

  (-)-3-[3-[(1R, 2R, 4S)-双环[2.2.1]庚-2-基氧基]-4-甲氧基苯胺基]-2-甲基-2-环戊烯-1-酮，或其水合物或溶液，或含有上述物质的药物组合物。
• REMEDIES FOR ALLERGIC EYE DISEASES
  申请人：Nikken Chemicals Company, Limited

  公开号：EP1410795A1

  公开（公告）日：2004-04-21

  An agent for the treatment of allergic eye disease containing a 3-anilino-2-cycloalkenone derivative having the formula (I): wherein R1 is an unsubstituted or substituted C1 to C8 alkyl group provided that an unsubstituted methyl group is excluded, a C3 to C7 cycloalkyl group, a C6 to C10 bicycloalkyl group or an indanyl group, etc., R2 is a C1 to C4 alkyl group, R3 is a hydrogen atom, a C1 to C5 alkyl group, a C3 to C7 cycloalkyl group, etc., R4 is a hydrogen atom, an unsubstituted or substituted C1 to C5 alkyl group, a halogen atom, etc., R5, R6, R7 and R8 are independently a hydrogen atom, a C1 to C5 alkyl group, etc., X is -(CR11R12)n- or NR13-, wherein n is 0 to 2, R11, R12 and R13 are independently a hydrogen atom, a C1 to C5 alkyl group, etc.

  一种治疗过敏性眼病的制剂，含有具有式(I)的3-苯胺基-2-环烯酮衍生物： 其中 R1 是未取代或取代的 C1 至 C8 烷基（但不包括未取代的甲基）、C3 至 C7 环烷基、C6 至 C10 双环烷基或茚基等，R2 是 C1 至 C4 烷基，R3 是氢原子、C1 至 C5 烷基、C3 至 C7 环烷基等、R4 是氢原子、未取代或取代的 C1 至 C5 烷基、卤素原子等，R5、R6、R7 和 R8 独立地是氢原子、C1 至 C5 烷基等，X 是-(CR11R12)n- 或 NR13-，其中 n 是 0 至 2，R11、R12 和 R13 独立地是氢原子、C1 至 C5 烷基等。
• Cycloalkenone derivative
  申请人：——

  公开号：US20040157933A1

  公开（公告）日：2004-08-12

  (−)-3-[3-[(1R, 2R, 4S)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one, or its hydrate or solvate, or a pharmaceutical composition containing the same.

  (-)-3-[3-[(1R, 2R, 4S)-双环[2.2.1]庚-2-氧基]-4-甲氧基苯胺]-2-甲基-2-环戊烯-1-酮，或其水合物或溶液，或含有上述物质的药物组合物。
• Remedies for allergic eye diseases
  申请人：——

  公开号：US20040220227A1

  公开（公告）日：2004-11-04

  An agent for the treatment of allergic eye disease containing a 3-anilino-2-cycloalkenone derivative having the formula (I): 1 wherein R 1 is an unsubstituted or substituted C 1 to C 8 alkyl group provided that an unsubstituted methyl group is excluded, a C 3 to C 7 cycloalkyl group, a C 6 to C 10 bicycloalkyl group or an indanyl group, etc., R 2 is a C 1 to C 4 alkyl group, R 3 is a hydrogen atom, a C 1 to C 5 alkyl group, a C 3 to C 7 cycloalkyl group, etc., R 4 is a hydrogen atom, an unsubstituted or substituted C 1 to C 5 alkyl group, a halogen atom, etc., R 5 , R 6 , R 7 and R 8 are independently a hydrogen atom, a C 1 to C 5 alkyl group, etc., X is —(CR 11 R 12 )n- or NR 13 —, wherein n is 0 to 2, R 11 , R 12 and R 13 are independently a hydrogen atom, a C 1 to C 5 alkyl group, etc.

  一种治疗过敏性眼病的制剂，含有一种具有式(I)的3-苯胺基-2-环烯酮衍生物： 1 其中 R 1 是未取代或取代的 C 1 至 C 8 烷基，但未取代的甲基除外，C 3 至 C 7 环烷基、C 6 至 C 10 双环烷基或茚基等，R 2 是 C 1 至 C 4 烷基，R 3 是氢原子、C 1 至 C 5 烷基 3 至 C 7 环烷基等，R 4 是氢原子、未取代或取代的 C 1 至 C 5 烷基、卤素原子等，R 5 , R 6 , R 7 和 R 8 独立地为氢原子、C 1 至 C 5 烷基等，X 是-(CR 11 R 12 )n-或 NR 13 -，其中 n 为 0 至 2，R 11 , R 12 和 R 13 独立地为氢原子、C 1 至 C 5 烷基等。
• AGENT FOR TREATMENT OF ALLERGIC EYE DISEASE
  申请人：Ina Shinji

  公开号：US20080306163A1

  公开（公告）日：2008-12-11

  An agent for the treatment of allergic eye disease containing a 3-anilino-2-cycloalkenone derivative having the formula (I): wherein R 1 is an unsubstituted or substituted C 1 to C 8 alkyl group provided that an unsubstituted methyl group is excluded, a C 3 to C 7 cycloalkyl group, a C 6 to C 10 bicycloalkyl group or an indanyl group, etc., R 2 is a C 1 to C 4 alkyl group, R 3 is a hydrogen atom, a C 1 to C 5 alkyl group, a C 3 to C 7 cycloalkyl group, etc., R 4 is a hydrogen atom, an unsubstituted or substituted C 1 to C 5 alkyl group, a halogen atom, etc., R 5 , R 6 , R 7 and R 8 are independently a hydrogen atom, a C 1 to C 5 alkyl group, etc., X is —(CR 11 R 12 ) n — or NR 13 —, wherein n is 0 to 2, R 11 , R 12 and R 13 are independently a hydrogen atom, a C 1 to C 5 alkyl group, etc.